Common gene version optimizes thinking -- but with a possible downside

User rating: 4.8 / 5 after 8 vote(s)

Most people inherit a version of a gene that optimizes their brain's thinking circuitry, yet also appears to increase risk for schizophrenia, a severe mental illness marked by impaired thinking, scientists at the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) have discovered. The seeming paradox emerged from the first study to explore the effects of variation in the human gene for a brain master switch, DARPP-32.


Full story »

All News summaries from Medicine & Health news
All News summaries for February 08, 2007

Booming business helps patients navigate medicine

45 minutes ago | User rating: not rated yet
(AP) -- After three surgeries, Judy Sherer still had chronic pain in her left shoulder. She'd lost faith in her doctors, and in despair tried a new health benefit offered by her employer.

Researchers identify gene responsible for rare childhood disease

53 minutes ago | User rating: not rated yet
The chromosomal abnormality that causes a rare, but often fatal, disorder that affects infants has been identified by researchers at the University of California, San Diego School of Medicine, who happened to treat two young ...

Genetic mutation identified for eye complaint

2 hours ago | User rating: not rated yet
An international research collaboration including research teams from the Children's Hospital in Boston (USA), King's College London and the Peninsula Medical School, has identified a gene that, when mutated, causes Duane ...

US fentanyl deaths topped 1,000 over 2 years

2 hours ago | User rating: not rated yet
(AP) -- More than 1,000 people died over two years from an illegal version of the painkiller fentanyl, the government reported Thursday in its first national tally of those deaths.

Officials: Search for HIV vaccine needs overhaul

2 hours ago | User rating: not rated yet
(AP) -- Scientists will have to take "enormous intellectual leaps" to develop an AIDS vaccine in the coming years, say researchers clearly frustrated by the failure of a once-promising shot.